Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia

MLA

Jean Khoury, et al. “Efficacy of Dasatinib for the Treatment of Intractable Chronic Myeloid Leukemia.” Journal of Blood Medicine, vol. 1, Sept. 2010, pp. 221–25. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....954068dd7b0bca3ca4c8b50e2149e5e2&authtype=sso&custid=ns315887.

APA

Jean Khoury, null Lima, null Arellano, null Holloway, null Shepard, & null McMillan. (2010). Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia. Journal of Blood Medicine, 1, 221–225.

Chicago

Jean Khoury, null Lima, null Arellano, null Holloway, null Shepard, and null McMillan. 2010. “Efficacy of Dasatinib for the Treatment of Intractable Chronic Myeloid Leukemia.” Journal of Blood Medicine 1 (September): 221–25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....954068dd7b0bca3ca4c8b50e2149e5e2&authtype=sso&custid=ns315887.